According to the report, the global glioblastoma market was valued at USD 2.46 billion in 2024 and is expected to reach USD 7.20 billion by 2034, expanding at a CAGR of 9.30% during the forecast period. The report highlights the increasing burden of brain cancers, advancements in therapeutic approaches, and rising investments in oncology research as major contributors to market growth.

Get a sample of the report @ https://www.emergenresearch.co....m/request-sample/271